This is a summary. To read the whole story subscribe to BostonGlobe.com
Colin Hill hopes that a company he founded 13 years ago, GNS Healthcare, will eventually help develop personalized treatment plans that take into account a patient’s particular history and biology. GNS is among the leaders in using Big Data analytics to learn more about diseases, patients, and treatments.
With all this information aggregated from thousands of cases, Hill said GNS uses artificial intelligence algorithms to determine what treatment made the crucial difference for each patient, and with it what is likely to work best for the next patient — rather than simply trying one medication after another, as is often done today.